BioXcel Therapeutics Forms Neuroscience Clinical Advisory Board to Support Global Development of BXCL501 - GlobeNewswire (press release)

BioXcel Therapeutics Forms Neuroscience Clinical Advisory Board to Support Global Development of BXCL501GlobeNewswire (press release)NEW HAVEN, Conn., July 10, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across ...